Loss of chromosomal integrity drives rat mammary tumorigenesis

International Journal of Cancer

Volumn 120, Issue 5, 2007, Pages 985-994

  Goepfert, Thea M ^a   Moreno Smith, Myrthala ^a   Edwards, David G ^a   Pathak, Sen ^b   Medina, Daniel ^a   Brinkley, W R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Aurora A kinase; Centrosome amplification; Genomic instability; Mammary gland carcinogenesis; Preneoplasia; Transplantation

Indexed keywords

AURORA A KINASE; CARCINOGEN; METHYLNITROSOUREA;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; CANCER INCIDENCE; CANCER TRANSPLANTATION; CELL GROWTH; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME LOSS; CONTROLLED STUDY; DIET; DIPLOIDY; DNA DAMAGE; ENVIRONMENTAL FACTOR; EXPOSURE; FEMALE; GENOMIC INSTABILITY; METAPHASE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; SUPERNUMERARY CHROMOSOME;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CENTROSOME; CHROMOSOMAL INSTABILITY; FEMALE; KARYOTYPING; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; NEOPLASM TRANSPLANTATION; POLYPLOIDY; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED WF;

EID: 33846796118     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22420     Document Type: Article

References (45)

1. Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 1996;39:7-20.
2. Russo J, Russo IH, Rogers AE, van Zwieten MJ, Gusterson B. Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the mammary gland. IARC Sci Publ 1990;99:47-78.
3. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, Conneely OM, O'Malley BW, Medina D. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis 1998;19:1573-81.
4. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 1985;45:3415-43.
5. Medina D. Preneoplasia in mammary tumorigenesis. Cancer Treat Res 1996;83:37-69.
6. Thompson HJ, Singh M, McGinley J. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia 2000;5:201-10.
7. Haslam SZ, Bern HA. Histopathogenesis of 7,12-diemthylbenz(a) anthracene-induced rat mammary tumors. Proc Natl Acad Sci USA 1977;74:4020-4.
8. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990;62:244-78.
9. Aldaz CM, Gollahon LS, Chen A. Chromosome alterations in rat mammary tumor progression. Prog Clin Biol Res 1992;376:137-53.
10. Haag JD, Brasic GM, Shepel LA, Newton MA, Grubbs CJ, Lubet RA, Kelloff GJ, Gould MN. A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumors. Mol Carcinog 1999;24:47-56.
11. Aldaz CM, Chen A, Gollahon LS, Russo J, Zappler K. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression. Cancer Res 1992;52:4791-8.
12. Sukumar S, Notario V, Martin-Zanca D, Barbacid M. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 1983;306:658-61.
13. Cha RS, Guerra L, Thilly WG, Zarbl H. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats. Carcinogenesis 1996;17:2519-24.
14. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004;117 (Part 8):1495-502.
15. McKenzie KE, Armstrong BA, Chen Y, Nagarajan M, Aldaz CM, Sukumar S. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors. Mol Carcinog 1997;20:194-203.
16. Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res 2002;62: 4115-22.
17. Isaacs JT. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 1986;46:3958-63.
18. Russo J, Calaf G, Roi L, Russo IH. Influence of age and gland topography on cell kinetics of normal human breast tissue. J Natl Cancer Inst 1987;78:413-8.
19. Ip MM, Asch BB. Methods in mammary gland biology and breast cancer research. Boston: Kluwer, 2000.
20. Deome KB, Faulkin LJ, Jr, Bern HA, Blair PB. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959;19:515-20.
21. Vindelov LL. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch B Cell Pathol Incl Mol Pathol 1977;24:227-42.
22. Arden KC, Pathak S, Swartzendruber DE, Zimmer SG. Cytogenetic characterization and DNA content analysis of Ad 2-transformed rat embryo brain cells. Anticancer Res 1984;4:367-74.
23. Pathak S. Chromosome banding techniques. J Reprod Med 1976;17:25-8.
24. deLucca EJ, Dhalival MK, Fuzlong DL, Pathak S. A high-resolution G-banding idiogram of Rattus norvegicus chromosomes. Cytobios 1990;62:153-60.
25. Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 1999;59:4276-84.
26. Ehmann UK, DeVries JT, Chen MS, Adamos AA, Guzman RC, Omary MB. An in vitro model of epithelial cell growth stimulation in the rodent mammary gland. Cell Prolif 2003;36:177-90.
27. Mack GJ, Rees J, Sandblom O, Balczon R, Fritzler MJ, Rattner JB. Autoantibodies to a group of centrosomal proteins in human autoimmune sera reactive with the centrosome. Arthritis Rheum 1998;41:551-8.
28. Dunn TB. Morphology of mammary tumors in mice with and without the agent. Acta Unio Int Contra Cancrum 1951;7:234-7.
29. Uehara N, Chou YC, Galvez JJ, de-Candia P, Cardiff RD, Benezra R, Shyamala G. Id-1 is not expressed in the luminal epithelial cells of mammary glands. Breast Cancer Res 2003;5:R25-R9.
30. Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF. Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J Cell Biol 1995;131:539-49.
31. Aldaz CM, Liao QY, Paladugu A, Rehm S, Wang H. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression. Mol Carcinog 1996;17(3):126-33.
32. See reference 10.
33. Li JJ, Papa D, Davis MF, Weroha SJ, Aldaz CM, El-Bayoumy K, Ballenger J, Tawfik O, Li SA. Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 2002;33:56-65.
34. Pathak S, Multani AS, Furlong CL, Sohn SH. Telomere dynamics, aneuploidy, stem cells, and cancer (review). Int J Oncol 2002;20:637-41.
35. Anderson CH, Beattie CW. Cellular kinetics of rat mammary gland terminal end bud epithelium exposed to N-methyl-N-nitrosourea in vivo. Cancer Res 1992;52:5076-81.
36. Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2002;2:815-25.
37. Tsou MF, Stearns T. Controlling centrosome number: licenses and blocks. Curr Opin Cell Biol 2006;18(1):74-8.
38. Loffler H, Lukas J, Bartek J, Kramer A. Structure meets function-centrosomes, genome maintenance and the DNA damage response. Exp Cell Res 2006;312:2633-40.
39. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70.
40. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA, Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005;434:907-13.
41. Goepfert TM, Brinkley BR. Centrosome anomalies in cancer: from early observations to animal modes. In: Nigg E, ed. Centrosomes in development and disease. Weinheim: Wiley-VCH, 2004. 323-33.
42. Sluder G, Nordberg JJ. The good, the bad and the ugly: the practical consequences of centrosome amplification. Curr Opin Cell Biol 2004;16:49-54.
43. Aldaz CM, Gollahon LS, Chen A. Systematic HRAS amplification in ovary-independent mammary tumors: correlation with progressively anaplastic phenotypes. Cancer Res 1993;53:5339-44.
44. Bartsch C, Szadowska A, Karasek M, Bartsch H, Geppert MDM. Serial transplants of DMBA-induced mammary tumors in fischer rats as model system for human breast cancer: V. Myoepithelial-mesenchymal conversion during passaging as possible cause for modulation of pineal-tumor interaction. Exp Toxicol Pathol 2000;52:93-101.
45. Kisseberth WC, Sandgren EP. Polyclonal development of mouse mammary preneoplastic nodules. Cancer Res 2004;64:857-63.